112 related articles for article (PubMed ID: 7089401)
1. [Premature ovarian insufficiency induced by alkylating agents (author's transl)].
Güitrón A; Martínez G; Forsbach G; Muñoz M; Joffre G; Galache P; Hernández-Ayup S
Rev Invest Clin; 1982; 34(1):59-61. PubMed ID: 7089401
[No Abstract] [Full Text] [Related]
2. [Pregnancy in a patient with premature ovarian failure secondary to chemotherapy].
Triantafilo Y; Arteaga E; Duque G; Fernández C; Grebe G
Rev Med Chil; 1991 Jan; 119(1):60-3. PubMed ID: 1824146
[TBL] [Abstract][Full Text] [Related]
3. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
Teinturier C; Hartmann O; Valteau-Couanet D; Benhamou E; Bougneres PF
Bone Marrow Transplant; 1998 Nov; 22(10):989-94. PubMed ID: 9849696
[TBL] [Abstract][Full Text] [Related]
4. Multisystem stem cell failure after apparent recovery from alkylating agents.
Botnick LE; Hannon EC; Hellman S
Cancer Res; 1978 Jul; 38(7):1942-7. PubMed ID: 657132
[No Abstract] [Full Text] [Related]
5. [Hypogonadism and alkylating agents (author's transl)].
Lecomte P; de Meeus MC; Lorette G; Lansac J; Soutoul JH
J Gynecol Obstet Biol Reprod (Paris); 1981; 10(6):597-602. PubMed ID: 7320455
[TBL] [Abstract][Full Text] [Related]
6. [Carcinogenic effects of anti neoplastic and immunosuppressive drugs].
Brock N; Schneider B
Arzneimittelforschung; 1971 Apr; 21(4):435-43. PubMed ID: 5108136
[No Abstract] [Full Text] [Related]
7. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function.
Oktem O; Oktay K
Cancer; 2007 Nov; 110(10):2222-9. PubMed ID: 17932880
[TBL] [Abstract][Full Text] [Related]
8. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Reh A; Oktem O; Oktay K
Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy].
Yang XY; Zhu X; Liang LQ; Zhan ZP; Ye YJ
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):960-2. PubMed ID: 16061002
[TBL] [Abstract][Full Text] [Related]
10. [Amenorrhea following chemotherapy for the treatment of breast carcinoma: a suitable criterion of ovarian insufficiency?].
Willemse PH; Sleijfer DT; Brouwers TM; van der Ploeg E; Doorenbos H
Ned Tijdschr Geneeskd; 1981 May; 125(20):775-9. PubMed ID: 7242729
[No Abstract] [Full Text] [Related]
11. Anovulation in the prevention of cytotoxic-induced follicular attrition and ovarian failure.
Letterie GS
Hum Reprod; 2004 Apr; 19(4):831-7. PubMed ID: 15033951
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of follicular reserve].
Belaisch-Allart J
Contracept Fertil Sex; 1999 Apr; 27(4):259-62. PubMed ID: 10349766
[No Abstract] [Full Text] [Related]
13. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.
Huong DL; Amoura Z; Duhaut P; Sbai A; Costedoat N; Wechsler B; Piette JC
J Rheumatol; 2002 Dec; 29(12):2571-6. PubMed ID: 12465154
[TBL] [Abstract][Full Text] [Related]
14. [Post-pill amenorrhea following hormonal contraceptive therapy in adolescence (author's transl)].
Brandt M; Schmeisser G; Schröder M
Arztl Jugendkd; 1981; 72(4):241-5. PubMed ID: 7337045
[TBL] [Abstract][Full Text] [Related]
15. Busulfan neurotoxicity and EEG abnormalities: a case report.
La Morgia C; Mondini S; Guarino M; Bonifazi F; Cirignotta F
Neurol Sci; 2004 Jun; 25(2):95-7. PubMed ID: 15221628
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.
Mok CC; Lau CS; Wong RW
Arthritis Rheum; 1998 May; 41(5):831-7. PubMed ID: 9588734
[TBL] [Abstract][Full Text] [Related]
17. Limitations of oral busulfan in preparative regimen before hematopoietic stem-cell transplantation.
Kami M; Hamaki T; Maruta Y; Miyakoshi S; Mutou Y
Haematologica; 2002 Feb; 87(2):ELT10. PubMed ID: 11836187
[No Abstract] [Full Text] [Related]
18. [Hyperprolactinemic ovarian insufficiency].
Smekal G; Huber H
Gynakol Rundsch; 1984; 24(3):191-3. PubMed ID: 6479693
[No Abstract] [Full Text] [Related]
19. Fertility options in young breast cancer survivors: a review of the literature.
Dow KH; Kuhn D
Oncol Nurs Forum; 2004 May; 31(3):E46-53. PubMed ID: 15152274
[TBL] [Abstract][Full Text] [Related]
20. Ovarian function and childbearing issues in breast cancer survivors.
Gadducci A; Cosio S; Genazzani AR
Gynecol Endocrinol; 2007 Nov; 23(11):625-31. PubMed ID: 17926162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
